Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published February 2015 | Accepted Version
Journal Article Open

Streptomyces: A Screening Tool for Bacterial Cell Division Inhibitors

Abstract

Cell division is essential for spore formation but not for viability in the filamentous streptomycetes bacteria. Failure to complete cell division instead blocks spore formation, a phenotype that can be visualized by the absence of gray (in Streptomyces coelicolor) and green (in Streptomyces venezuelae) spore-associated pigmentation. Despite the lack of essentiality, the streptomycetes divisome is similar to that of other prokaryotes. Therefore, the chemical inhibitors of sporulation in model streptomycetes may interfere with the cell division in rod-shaped bacteria as well. To test this, we investigated 196 compounds that inhibit sporulation in S. coelicolor. We show that 19 of these compounds cause filamentous growth in Bacillus subtilis, consistent with impaired cell division. One of the compounds is a DNA-damaging agent and inhibits cell division by activating the SOS response. The remaining 18 act independently of known stress responses and may therefore act on the divisome or on divisome positioning and stability. Three of the compounds (Fil-1, Fil-2, and Fil-3) confer distinct cell division defects on B. subtilis. They also block B. subtilis sporulation, which is mechanistically unrelated to the sporulation pathway of streptomycetes but is also dependent on the divisome. We discuss ways in which these differing phenotypes can be used in screens for cell division inhibitors.

Additional Information

© 2014 Society for Laboratory Automation and Screening. Received May 8, 2014, and in revised form Jan 16, 2014. Accepted for publication Aug 10, 2014. Published online before print September 25, 2014. We thank R. E. Yasbin, University of Missouri–St. Louis, for kindly providing the stain containing dinC-lacZ fusion (dinC18::Tn917Iac metB5 trpC2 xin-1 SPβ– amyE+, strain ID—YB5018) and Bacillus Genetic Stock Centre (BGSC) for providing liaI-lacZ fusion strain (Em trpC2 liaI::pMUTIN attSPbeta, BGSC ID—1A980). Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by funding from the Canadian Institute for Health Research (grant MOP-133636) and NIH (R01 grant GM094800B to GJJ).

Attached Files

Accepted Version - nihms787173.pdf

Files

nihms787173.pdf
Files (989.8 kB)
Name Size Download all
md5:62e181cda3036892e1fdbca2599988a1
989.8 kB Preview Download

Additional details

Created:
August 20, 2023
Modified:
October 17, 2023